The negative regulation of p53wt by MK2 described herein provides a molecular mechanism for the pro-tumorigenic functions of MK2 in p53wt glioblastomas, extending the previous data showing tumor progression through MK2 signaling in skin, colorectal and intestinal cancers [2,4,43]. Here, MAPKAPK2 is linked to glioblastoma.